Drug development services including preclinical evaluation (animal and analytical), development, and translation of drug products and technologies that improve healthcare outcomes. Access to equipment and services, such as small animal studies (mice, rats, hamsters), cell culture, material characterization (NGI, Spraytec, Zetasizer), formulation development, dissolution and stability studies, as well as quantitative small molecule HPLC and mass spec analyses.